Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy.

Kyoko ShimadaShoji NagaoKazuhiro SuzukiTakashi ShibutaniKasumi YamamotoTomoatsu JimiHiroko YanoMiho KitaiTakaya ShiozakiSatoshi Yamaguchi

Published in: International journal of clinical oncology (2020)

Based on the data analyzed here, a suppressive effect on carboplatin-induced HSR via combination therapy with PLD was confirmed within clinical practice.

Keyphrases

combination therapy
clinical practice
phase ii study
drug induced
drug delivery
squamous cell carcinoma
clinical trial
oxidative stress
rectal cancer
data analysis